[(1S,4aR,5R,7S,7aS)-5-hydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-7-yl] acetate

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: [(1S,4aR,5R,7S,7aS)-5-hydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-7-yl] acetate
• 化学式: C₁₇H₂₆O₁₀
• 分子量: 390.4
• InChiKey: FLOXQRMTDDOZKF-MUIWGTDSSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.6
• 重原子数：
  27
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.82
• 拓扑面积：
  155
• 氢给体数：
  5
• 氢受体数：
  10

文献信息

• COMPOSITION FOR TREATING FATTY LIVER
  申请人：Nasu, Masanori

  公开号：EP3653219A1

  公开（公告）日：2020-05-20

  A composition for treating fatty liver which comprises extracts of ginseng, Atractylodes rhizome, Crataegus cuneate, Alisma tuber and Cassia obtusifolia L.

  一种治疗脂肪肝的组合物，由人参、白术、楔形山楂、泽泻和决明子的提取物组成。
• Composition for treating fatty liver
  申请人：Nasu Masanori

  公开号：US10849950B2

  公开（公告）日：2020-12-01

  A composition for treating fatty liver which comprises extracts of ginseng, Atractylodes rhizome, Crataegus cuneate, Alisma tuber and Cassia obtusifolia L.

  一种治疗脂肪肝的组合物，由人参、白术、楔形山楂、泽泻和决明子的提取物组成。
• Chinese traditional medicines for psoriasis
  申请人：——

  公开号：US20030152588A1

  公开（公告）日：2003-08-14

  The invention relates to disclose some Chinese formula for psoriasis. Whether treatment for psoriasis is targeted at both the hyperproliferative and inflammatory aspect of the topical therapy. Specially, the administration dosage is soft gel, cream, tincture and aerosol etc. topical dosages.
• SYNERGISTIC ANTI-HYPERTENSIVE PHYTO-NUTRACEUTICAL COMPOSITION
  申请人：OLALDE RANGEL JOSE ANGEL

  公开号：US20080267939A1

  公开（公告）日：2008-10-30

  A Phyto-nutraceutical composition for the prevention and treatment of hypertensive disorders is provided. A specific combination of extracts of plants and nutraceuticals is provided, based on categorizing plants and nutraceuticals into one of three groups, Energy, Bio-Intelligence, and Organization. Such combinations have synergistic effects, with minimal side effect.
• Extracts of Cranberry and Methods of Using Thereof
  申请人：Alberte Randall S.

  公开号：US20100028469A1

  公开（公告）日：2010-02-04

  The present disclosure relates in part to extracts of cranberry ( Vaccinium macrocarpon ) comprising an enriched amount of certain compounds having anti-infective activity, e.g. antibacterial and/or antifungal activity, e.g. activity against C. albicans . Another aspect of the disclosure relates to combined cranberry and cinnamon extracts. In certain embodiments, these combined extracts have been optimized to control urinary tract infections caused by E. coli, S. aureus and C. albicans . Certain embodiments of the extract are enriched in bioactive compounds that have been shown to inhibit C. albicans adhesion and/or biofilm formation and its growth in vitro. In another aspect of the disclosure, the extracts are enriched in bioactives derived from cranberry and cinnamon that have been shown to inhibit the attachment and the growth of common urinary tract pathogens like E. coli, S. aureus and C. albicans.